Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Targeting human oligodendrocyte progenitors for myelin repair.
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Towards establishing MS prevalence in Latin America and the Caribbean.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Pediatric multiple sclerosis in Venezuela.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
The translational biology of remyelination: Past, present, and future.
[Posture disorders in patients with multiple sclerosis.]
Coping strategies and mood profiles in patients with multiple sclerosis.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
The prospects of minocycline in multiple sclerosis.
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »